Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

- PMLiVE

Top-10 ways for Pharma to leverage AI according to…AI

Like most people these days, I have been experimenting with various artificial intelligence (AI) tools this past year. It’s remarkable to see the progress made in the technology compared to...

Impetus Digital

- PMLiVE

Eli Lilly announces new $4.5bn US site for manufacturing and drug development

The Lilly Medicine Foundry is expected to add 400 full-time jobs for highly skilled workers

- PMLiVE

GSK receives CHMP recommendation for meningococcal disease vaccine Menveo

The new presentation would offer healthcare providers an option that does not require reconstitution before use

- PMLiVE

NHS England begins newborn screening programme to identify rare genetic conditions

The Generation Study is aiming to screen 100,000 newborns for more than 200 diseases

- PMLiVE

Beyond awareness: How employers can support those with chronic health conditions like PCOS

As part of PCOS Awareness Month, Dr Tayyibah Ali takes a look at the ways employers can help support colleagues with chronic conditions like PCOS

Mednet

- PMLiVE

Unlocking innovation: The power of diversity at Mednet

We explore how diversity and inclusion drive the innovation that's critical to business success.

Mednet

- PMLiVE

How patients are transforming cancer care: insights from ESMO on patient-centric oncology

By Inizio

- PMLiVE

Stats without stories: why journalists aren’t covering your data

By Christopher Silverwood

- PMLiVE

Results from Global Pharmaceutical Customer Experience survey

UCB and J&J Innovative Medicine come out on top, while customer experience is in a state of flux

- PMLiVE

Sanofi/Regeneron’s Dupixent approved by FDA to treat uncontrolled COPD

Approximately 300,000 patients in the US will be eligible for the therapy

- PMLiVE

Roche’s Genentech acquires Regor Pharmaceuticals’ CDK inhibitors for $850m upfront

One of the candidates included in the deal has already shown promise in a phase 1a advanced breast cancer study

- PMLiVE

J&J and Legend share long-term results for Carvykti in phase 3 multiple myeloma study

More than 35,000 people are expected to be diagnosed with the blood cancer in the US this year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links